Subchronic rolipram delivery activates hippocampal CREB and Arc, enhances retention and slows down extinction of conditioned fear

Neuropsychopharmacology

Volumn 31, Issue 2, 2006, Pages 278-286

  Monti, Barbara ^a   Berteotti, Chiara ^a   Contestabile, Antonio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Arc expression; Conditioned fear learning; CREB activity; Hippocampus; Memory consolidation; Memory extinction; Rat

Indexed keywords

CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PROTEIN; PROTEIN ARC; ROLIPRAM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEAR; HIPPOCAMPUS; LEARNING; LEARNING TEST; MALE; MEMORY CONSOLIDATION; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; CONDITIONING (PSYCHOLOGY); CREB-BINDING PROTEIN; CYTOSKELETAL PROTEINS; DRUG ADMINISTRATION SCHEDULE; EXTINCTION, PSYCHOLOGICAL; FEAR; FREEZING REACTION, CATALEPTIC; HIPPOCAMPUS; MALE; NERVE TISSUE PROTEINS; RATS; RATS, WISTAR; RETENTION (PSYCHOLOGY); ROLIPRAM; TIME FACTORS;

EID: 30944445595     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300813     Document Type: Article

References (64)

1. Ahi J, Radulovic J, Spiess J (2004). The role of hippocampal signaling cascades in consolidation of fear memory. Behav Brain Res 149: 17-31.
2. Athos J, Impey S, Pineda VV, Chen X, Storm DR (2002). Hippocampal CRE-mediated gene expression is required for contextual memory formation. Nat Neurosci 5: 1119-1120.
3. Barad M, Bourtchouladze R, Winder DG, Golan H, Kandel E (1998). Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. Proc Natl Acad Sci USA 95: 15020-15025.
4. Barco A, Pittenger C, Kandel ER (2003). CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects. Expert Opin Ther Targets 7: 101-114.
5. Bourtchuladze R, Frenguelli B, Blendy J, Cioffi D, Schutz G, Silva AJ (1994). Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 79: 59-68.
6. Bourtchouladze R, Lidge R, Catapano R, Stanley J, Gossweiler S, Romashko D et al (2003). A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4. Proc Natl Acad Sci USA 100: 10518-10522.
7. Chang YC, Huang AM, Kuo YM, Wang ST, Chang YY, Huang CC (2003). Febrile seizures impair memory and cAMP response-element binding protein activation. Ann Neurol 54: 706-718.
8. Corcoran KA, Maren S (2001). Hippocampal inactivation disrupts contextual retrieval of fear memory after extinction. J Neurosci 21: 1720-1726.
9. Egawa T, Mishima K, Matsumoto Y, Iwasaki K, Iwasaki K, Fujiwara M (1997). Rolipram and its optical isomers, phosphodiesterase 4 inhibitors, attenuated the scopolamine-induced impairments of learning and memory in rats. Jpn J Pharmacol 75: 275-281.
10. Fanselow MS (1986). Associative vs topographical accounts of the immediate shock freezing deficit in rats: implications for the response selection rules governing species specific defensive reactions. Learn Motivation 17: 16-39.
11. Fanselow MS (1990). Factors governing one trial contextual conditioning. Animal Learn Behav 18: 264-270.
12. Fischer A, Sananbenesi F, Schrick C, Spiess J, Radulovic J (2004). Distinct roles of hippocampal de novo protein synthesis and actin rearrangement in extinction of contextual fear. J Neurosci 24: 1962-1966.
13. Frey U, Huang YY, Kandel ER (1993). Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 260: 1661-1664.
14. Fujimaki K, Morinobu S, Duman RS (2000). Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus. Neuropsychopharmacology 22: 42-51.
15. Fujioka T, Fujioka A, Duman RS (2004). Activation of cAMP signaling facilitates the morphological maturation of newborn neurons in adult hippocampus. J Neurosci 24: 319-328.
16. Giorgi M, Modica A, Pompili A, Pacitti C, Gasbarri A (2004). The induction of cyclic nucleotide phosphodiesterase 4 gene (PDE4D) impairs memory in a water maze task. Behav Brain Res 154: 99-106.
17. Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, Arancio O (2004). Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after Rolipram treatment. J Clin Invest 114: 1624-1634.
18. Guzowski JF, Lyford GL, Stevenson GD, Houston FP, McGaugh JL, Worley PF et al (2000). Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. J Neurosci 20: 3993-4001.
19. Guzowski JF, Setlow B, Wagner EK, McGaugh JL (2001). Experience-dependent gene expression in the rat hippocampus after spatial learning. A comparison of the immediate-early genes Arc, c-fos, and zif268. J Neurosci 21: 5089-5098.
20. Imanishi T, Sawa A, Ichimaru Y, Miyashiro M, Kato S, Yamamoto T et al (1997). Ameliorating effects of Rolipram on experimentally induced impairments of learning and memory in rodents. Eur J Pharmacol 321: 273-278.
21. Impey S, Smith DM, Obrietan K, Donahue R, Wade C, Storm DR (1998). Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning. Nat Neurosci 1: 595-601.
22. Inoue K, Fukazawa Y, Ogura A, Inokuchi K (2005). Two-dimensional neural activity mapping of the entire population of hippocampal CA1 pyramidal cells responding to fear conditioning. Neurosci Res 51: 417-425.
23. Itho T, Tokumura M, Abe K (2004). Effects of Rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats. Eur J Pharmacol 498: 135-142.
24. Jackson T, Ramaswami M (2003). Prospects of memory-modifying drugs that target the CREB pathway. Curr Opin Drug Discov Devel 6: 712-719.
25. Lee JL, Everitt BJ, Thomas KL (2004). Independent cellular processes for hippocampal memory consolidation and reconsolidation. Science 304: 839-843.
26. Lin CH, Yeh SH, Lu HY, Gean PW (2003). The similarities and diversities of signal pathways leading to consolidation of conditioning and consolidation of extinction of fear memory. J Neurosci 23: 8310-8317.
27. Lonze BE, Ginty DD (2002). Function and regulation of CREB family transcription factors in the nervous system. Neuron 35: 605-623.
28. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
29. Lyford GL, Yamagata K, Kaufmann WE, Barnes CA, Sanders LK, Copeland NG et al (1995). Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 14: 433-445.
30. Montag-Sallaz M, Montag D (2003). Learning-induced arg 3.1/arc mRNA expression in the mouse brain. Learn Mem 10: 99-107.
31. Nakagawa S, Kim JE, Lee R, Chen J, Fujioka T, Malberg J et al (2002b). Localization of phosphorylated cAMP response element-binding protein in immature neurons of adult hippocampus. J Neurosci 22: 9868-9876.
32. Nakagawa S, Kim JE, Lee R, Malberg JE, Chen J, Steffen C et al (2002a). Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J Neurosci 22: 3673-3682.
33. Nagakura A, Niimura M, Takeo S (2002). Effects of a phosphodiesterase IV inhibitor Rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats. Br J Pharmacol 135: 1783-1793.
34. Navakkode S, Sajikumar S, Prey JU (2004). The type IV-specific phosphodiesterase inhibitor Rolipram and its effect on hippocampal long-term potentiation and synaptic tagging. J Neurosci 24: 7740-7744.
35. Nguyen PV, Woo NH (2003). Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases. Prog Neurobiol 71: 401-437.
36. Nibuya M, Nestler EJ, Duman RS (1996). Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16: 2365-2372.
37. Phillips RG, LeDoux JE (1994). Lesions of the dorsal hippocampal formation interfere with background but not foreground contextual fear conditioning. Learn Mem 1: 34-44.
38. 2+-stimulated adenylyl cyclases in LTP and memory formation. Int J Dev Neurosci 19: 387-394.
39. Quinn JJ, Oommen SS, Morrison GE, Fanselow MS (2002). Post-training excitotoxic lesions of the dorsal hippocampus attenuate forward trace, backward trace, and delay fear conditioning in a temporally specific manner. Hippocampus 12: 495-504.
40. Rescorla RA (2001). Experimental extinction. In: Mowrer RR, Klein S (eds). Handbook of Contemporary Learning Theories. Erlbaum: Mahwah, NJ. pp 119-154.
41. Rogelj B, Hartmann CE, Yeo CH, Hunt SP, Giese KP (2003). Contextual fear conditioning regulates the expression of brain-specific small nucleolar RNAs in hippocampus. Eur J Neurosci 18: 3089-3096.
42. Sanders MJ, Wiltgen BJ, Fanselow MS (2003). The place of the hippocampus in fear conditioning. Eur J Pharmacol 463: 217-223.
43. Sato T, Tanaka K, Ohnishi Y, Teramoto T, Irifune M, Nishikawa T (2004). Inhibitory effects of group II mGluR-related drugs on memory performance in mice. Physiol Behav 80: 747-758.
44. Silvestre JS, Fernandez AG, Palacios JM (1999a). Effects of Rolipram on the elevated plus-maze test in rats: a preliminary study. J Psychopharmacol 13: 274-277.
45. Silvestre JS, Fernandez AG, Palacios JM (1999b). Preliminary evidence for an involvement of the cholinergic system in the sedative effects of Rolipram in rats. Pharmacol Biochem Behav 64: 1-5.
46. Schneider HH (1984). Brain cAMP response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitation. Biochem Pharmacol 33: 1690-1693.
47. Suzuki A, Josselyn SA, Frankland PW, Masushige S, Silva AJ, Kida S (2004). Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci 24: 4787-4795.
48. Szapiro G, Galante JM, Barros DM, Levi de Stein M, Vianna MR, Izquierdo LA et al (2002). Molecular mechanisms of memory retrieval. Neurochem Res 27: 1491-1498.
49. Taubenfeld SM, Milekic MH, Monti B, Alberini CM (2001b). The consolidation of new but not reactivated memory requires hippocampal C/EBPbeta. Nat Neurosci 4: 813-818.
50. Taubenfeld SM, Wiig KA, Bear MF, Alberini CM (1999). A molecular correlate of memory and amnesia in the hippocampus. Nat Neurosci 2: 309-310.
51. Taubenfeld SM, Wiig KA, Monti B, Dolan B, Polionini G, Alberini CM (2001a). Fornix-dependent induction of hippocampal CCAAT enhancer-binding protein (beta) and (delta) co-localizes with phosphorylated cAMP response element-binding protein and accompanies long-term memory consolidation. J Neurosci 21: 84-91.
52. Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M (2002). Amyloid beta-peptide inhibition of the PKA/CREB pathway and long-term potentiation. Reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci USA 99: 13217-13221.
53. 2+ and cAMP requires protein kinase A and mitogen-activated protein kinase/extracellular regulated kinase activation. J Neurosci 21: 5484-5493.
54. Wang H, Ferguson GD, Pineda VV, Cundiff PE, Storm DR (2004). Overexpression of type-1 adenylyl cyclase in mouse forebrain enhances recognition memory and LTP. Nat Neurosci 7: 635-642.
55. Wang H, Storm DR (2003). Calmodulin-regulated adenylyl cyclases. Cross-talk and plasticity in the central nervous system. Mol Pharmacol 63: 463-468.
56. Weishaar RE, Cain MH, Bristol JA (1985). A new generation of phosphodiesterase inhibitors. Multiple molecular forms of phosphodiesterase and the potential for drug selectivity. J Med Chem 28: 537-545.
57. Westbrook RF, Good AJ, Kiernan MJ (1994). Effects of the interval between exposure to a novel environment and the occurrence of shock on the freezing responses of rats. Q J Exp Psychol B 47: 427-446.
58. Woolf NJ, Milov AM, Schweitzer ES, Roghani A (2001). Elevation of nerve growth factor and antisense knockdown of TrkA receptor during contextual memory consolidation. J Neurosci 21: 1047-1055.
59. Woolf NJ, Zinnerman MD, Johnson GV (1999). Hippocampal microtubule-associated protein-2 alterations with contextual memory. Brain Res 821: 241-249.
60. Ying SW, Futter M, Rosenblum K, Webber MJ, Hunt SP, Bliss TV et al (2002). Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J Neurosci 22: 1532-1540.
61. Zhang HT, Crissman AM, Dorairaj NR, Chandler LJ, O'Donnell JM (2004). Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism. Neuropsychopharmacology 23: 198-204.
62. Zhang HT, Huang Y, Suvarna NU, Deng C, Crissman AM, Hopper AT et al (2005). Effects of the novel PDE4 inhibitors MEM1018 and MEM1091 on memory in the radial-arm maze and inhibitory avoidance tests in rats. Psychopharmacology, in press (originally published online Jan 26, 2005).
63. Zhang HT, O'Donnell JM (2000). Effects of Rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats. Psychopharmacology 150: 311-316.
64. Zhang HT, Zhao Y, Huang Y, Dorairaj NR, Chandler LJ, O'Donnell JM (2000). Inhibition of the phosphodiesterase 4 (PDE4) enzyme reverses memory deficits produced by infusion of the MEK inhibitor U0126 into the CA1 subregion of the rat hippocampus. Neuropsychopharmacology 29: 1432-1439.